In-vitro and Clinical Evaluation of Triphala Ointment for Leucorrhoea

In vitro study of Triphala ointment and Randomized control trial of Triphala ointment in Leucorrhoea (Shwetapradar) - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/12/098875

Enrollment

Registered

2025-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures Health Condition 2: 8- Other Procedures

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: per vaginal white discharge with vulval itching as associated synptoms with healthy cervix

Exclusion criteria

Exclusion criteria: 1 vaginal secretions because of existing disease like polyp bartholin abscess malignant conditions etc 2 HIV HBSAG VDRL Positive patient 3 All pregnant women

Design outcomes

Primary

Measure	Time frame
Triphala Ointment may show comparable or superior efficacy to clotrimazole in relieving symptomsTimepoint: 7 days	—

Secondary

Measure	Time frame
It may offer additional benefits like no recurrence better tissue healing & no side effects due to its rasayana & shothahara propertiesTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Rahul Gajare

Bharati Vidyapeeth (Deemed to be University)

drrahulngajare35@gmail.com9890506779

Outcome results